Adherence to treatment of patients with past ischemic stroke.
Keywords:consequences of ischemic stroke, general practice-family medicine, Morissky-Green scale, secondary prevention, adherence to treatment
The main task of the general practitioner is managing patients with the effects of ischemic stroke. The improvement of patients adherence to treatment in a significant way contributes to successful secondary prevention of ischemic stroke. Adherence to treatment can be determined through various questionnaires, including Morissky-Green. Currently, the adherence to a long-term drug therapy remains insufficient.
Kovalenko VM, Kornac'kyj VM. [Diseases of the circulatory systemas a medical and social and socio-political problem]. Analitychno-statystychnyjposibnyk. Кyiv. 2014;279. Ukrainian.
Lukina JuV, Marcevich SJu, Kutishenko NP. [Morissky-Greene scale: the pros and cons of universal test, work on mistakes]. Racional'naja farmakoterapija v kardiologii. 2016;12(1):63-65. Russian.
Radchenko GD, Sirenko JuM, Martsovenko ІM. [Adherence to the treatment of patients with arterial hypertension and its changes on the background of therapy. Results of open prospective multicenter study]. Ukrai'ns'kyj kardiologichnyj zhurnal. 2010;3:44-57. Ukrainian.
Suslina ZA, Fonjakin AV,Geraskina LA.[Ischemic stroke and heart: from pathogenesis to prevention]. Klinich. farmakol. i terapija. 2003;5:47-51. Russian.
Shandalin VA, Fonjakin AV,Geraskina LA.[Secondary prevention of ischemic stroke: from recommendations to real clinical practice]. Zhurnal nevrologii, nejropsihiatrii i psihosomatiki. 2012;2:35-41. Russian.
Chobian AV. The Hypertension Paradox – more uncontrolled disease despite improved therapy. N. Engl. J. Med. 2009;361(15):15-16.
Global Burden of Disease Study 2016 (GBD 2016) Data Resources. Available from: ghdx.healthdata.org/gbd-2016.
Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack. A guideline for healthсare professionals from the American heart association. American stroke association. Stroke. 2011;42:227-76.
Jamison J, et al. Barriers and facilitators to adherence to secondary stroke prevention medications afters troke: analysis of survivors and caregivers views from an online stroke forum. BMJ Open 2017;7:e016814. doi: 10.1136/bmjopen-2017-01681
Haynes RB, Teylor DW, Sackett DL. Compliance in healthcare. Baltimor: TheJohnsHopkinsUniversityPress; 1979.
Jamison J, Graffy J, Mullis R, MantJ, Sutton S. Barriers to medication adherence for the secondary prevention of stroke: a qualitative interview study in primary care. Br J Gen Pract. 2016;66(649):e568-76. Published online 2016 May 24. doi: 10.3399/bjgp16X685609
Lago A,·Tembl JI,·Pareja A, Ponz A,·Ferrer JM, Vallés J, Santos MT. Adherence to aspirin in secondary prevention of ischemic stroke. Cerebrovasc Dis 2006;21:353-6. https://doi.org/10.1159/000091542
Kulkarni SP, Alexander KP, Lytleetal B. Long-Term adherence with cardiovascular drug regimens. Am. Heart J. 2006;151(1):185-91.
MoriskyDE, Ang A, Krousel-Wood M, Harry J. Ward. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348-54.
Sabate E. Adherence to long-term therapies: evidence for action.Geneva: WHO; 2003.
Simpson E, Eurich DT, Majumdaretal SR. A meta-analysis of the association between adherence to drugtherapy and mortality. BMJ. 2006;333:15.
How to Cite
Copyright (c) 2018 Medicni perspektivi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.